Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Drug Regulation01:25

Drug Regulation

3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

996
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
996
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor- and unit-specific factors influencing hemolysis in stored canine and feline packed red blood cells.

Frontiers in veterinary science·2026
Same author

Roadmapping stroke healthcare in Colombia: a comprehensive telestroke network evaluation.

BMC medical informatics and decision making·2026
Same author

PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity.

Science advances·2026
Same author

Increasing Kidney Transplant Volume With Higher Kidney Donor Risk Index Kidneys: A Call for Action in the United States.

Transplantation·2026
Same author

Outcomes of Kidney Transplants From Donors With Stage 3 Acute Kidney Injury Requiring Dialysis: A National Cohort Study.

Clinical transplantation·2026
Same author

Exploring metabolomic clues in diabetic retinopathy: a pilot study.

Acta diabetologica·2026

Related Experiment Video

Updated: Apr 29, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

The general practice research database: role in pharmacovigilance.

Louise Wood1, Carlos Martinez

  • 1General Practice Research Database Division, Medicines and Healthcare products Regulatory Agency, London, UK. louise.wood@gprd.com

Drug Safety
|September 16, 2004
PubMed
Summary

The General Practice Research Database (GPRD) offers extensive anonymized clinical data for drug safety. Its pharmacoepidemiological studies support regulatory pharmacovigilance and risk management planning.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1.1K

Related Experiment Videos

Last Updated: Apr 29, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1.1K

Area of Science:

  • Pharmacovigilance and Pharmacoepidemiology
  • Health Informatics
  • Primary Care Research

Background:

  • The General Practice Research Database (GPRD) is a significant global resource for anonymized longitudinal primary care clinical records.
  • GPRD data has established a strong international reputation in drug safety signal evaluation.
  • The database's characteristics support proactive pharmacovigilance within risk management frameworks.

Purpose of the Study:

  • To present recent developments and new data within the GPRD.
  • To describe the utility of GPRD data for various pharmacovigilance applications.
  • To discuss the future potential of GPRD for signal detection and evaluating pharmacovigilance impact.

Main Methods:

  • Utilizing anonymized longitudinal clinical records from primary care.
  • Analysis of spontaneously recorded suspected adverse drug reactions.
  • Pharmacoepidemiological study design for drug safety signal evaluation.

Main Results:

  • GPRD data is instrumental in informing regulatory pharmacovigilance decisions.
  • The database supports proactive pharmacovigilance and risk management.
  • New data, including adverse drug reactions, enhances GPRD's utility.

Conclusions:

  • The GPRD is a vital resource for drug safety signal evaluation and regulatory decision-making.
  • Its comprehensive data supports proactive pharmacovigilance and risk management.
  • Future applications include advanced signal detection and assessment of pharmacovigilance effectiveness.